Gut epithelial cell surface molecules

Gut epithelial cell surface molecules represent a diverse array of proteins, including receptors, transporters, and adhesion molecules, located on the apical and basolateral membranes of enterocytes and other specialized epithelial cells [1][3]. These molecules are critical for maintaining the intestinal barrier, facilitating nutrient and ion transport, and mediating communication between the host immune system and the gut microbiota [3][5]. Key therapeutic targets within this group include Guanylate cyclase C (GUCY2C), which regulates fluid secretion and is targeted by drugs like linaclotide for irritable bowel syndrome, and various transporters like NHE3 and SGLT1 [1][4]. Additionally, surface molecules such as EpCAM and CEACAMs are often overexpressed in colorectal cancers, serving as targets for monoclonal antibodies and imaging agents [4]. Dysregulation of these surface molecules is central to the pathogenesis of inflammatory bowel disease (IBD), celiac disease, and enteric infections [5]. Therapeutic strategies often involve modulating these proteins to restore barrier integrity, manage chronic constipation, or deliver drugs locally to the gastrointestinal tract [1][4].

Other names

Intestinal epithelial surface proteinsEnterocyte surface markersGut mucosal surface moleculesIntestinal cell surface receptorsApical membrane proteins of the gut

Agonism of Guanylate cyclase C (GUCY2C) to stimulate intracellular cGMP and fluid secretion; Inhibition of Sodium-hydrogen exchanger 3 (NHE3) to reduce sodium absorption; Inhibition of Sodium-glucose cotransporter 1 (SGLT1) to block glucose and sodium uptake; Activation of chloride channels (e.g., ClC-2) to promote intestinal fluid transit.